Jan 7 (Reuters) - Icosavax Inc ICVX.O :
* ICOSAVAX PROVIDES CORPORATE UPDATE AND ANTICIPATED
MILESTONES
FOR 2022
* ICOSAVAX INC - HAS AN UNAUDITED PRELIMINARY CASH POSITION,
INCLUDING RESTRICTED CASH, OF $281 MILLION AS OF DECEMBER 31,
2021
* ICOSAVAX INC - CURRENTLY EXPECTS ITS CASH BALANCE TO BE
SUFFICIENT TO FUND OPERATIONS THROUGH AT LEAST 2024
* ICOSAVAX INC - EVALUATING IVX-411, A SARS-COV-2 VLP
VACCINE
CANDIDATE, AGAINST OMICRON VARIANT
Source text for Eikon: ID:nGNX9321Vt
Further company coverage: ICVX.O
((Reuters.Briefs@thomsonreuters.com;))